Key metrics

Price as of 2026-10-16

Stock price
₹3.02
Market cap
55 Cr
Stock P/E
13.1
P/B
0.57
ROE (FY26)
4.7%
ROCE (FY26)
5.9%
Operating margin (FY26)
2.2%
Debt / equity (FY26)
0.19
OCF / EBITDA (FY26)
-91.7%
OCF / EBITDA (3Y)
-225.2%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Ajooni Biotech Limited makes cattle feed and sells it to customers in India and abroad.

Company snapshot

5thBy market cap

Ranked among 5 companies in Animal Feed.

What we see

Positives
  • ✓Debt-to-equity of 0.19x — the company is largely funded by its own money, not borrowed funds.
Concerns
  • ✗Net margin is very thin at 2.4% — little room for error if costs rise.
1 more signal from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales19 Cr20 Cr20 Cr26 Cr26 Cr34 Cr29 Cr31 Cr32 Cr59 Cr61 Cr63 Cr
Operating expenses (approx.)19 Cr21 Cr18 Cr25 Cr25 Cr33 Cr28 Cr31 Cr30 Cr56 Cr60 Cr62 Cr
EBITDA0.64 Cr-0.66 Cr2 Cr0.96 Cr0.77 Cr0.93 Cr1 Cr0.71 Cr2 Cr3 Cr1 Cr2 Cr
OPM %3.3%-3.3%8.1%3.8%3.0%2.7%3.5%2.3%4.7%5.2%1.7%2.6%
Other income0.29 Cr2 Cr0.26 Cr0.04 Cr0.31 Cr0.39 Cr1 Cr0.65 Cr0.15 Cr0.32 Cr1 Cr0.27 Cr
Interest0.19 Cr0.12 Cr0.11 Cr0.15 Cr0.06 Cr0.07 Cr0.06 Cr0.08 Cr0.17 Cr0.18 Cr0.29 Cr0.48 Cr
Depreciation0.21 Cr0.21 Cr0.24 Cr0.22 Cr0.23 Cr0.24 Cr0.38 Cr0.25 Cr0.25 Cr0.81 Cr0.90 Cr0.80 Cr
Profit before tax0.52 Cr0.58 Cr1 Cr0.63 Cr0.79 Cr1 Cr2 Cr1 Cr1 Cr2 Cr1 Cr0.65 Cr
Tax %22.3%24.5%38.9%25.2%22.6%27.7%19.2%23.9%24.4%30.1%15.5%34.0%
Net profit0.40 Cr0.44 Cr0.91 Cr0.47 Cr0.62 Cr0.73 Cr2 Cr0.78 Cr0.93 Cr2 Cr0.95 Cr0.43 Cr
EPS (₹)₹0.23₹0.25₹0.10₹0.03₹0.04₹0.04₹0.09₹0.02₹0.08₹0.10₹0.05₹0.01

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales29 Cr51 Cr74 Cr74 Cr80 Cr115 Cr182 CrSign in free for the trailing twelve months
Operating expenses (approx.)28 Cr49 Cr71 Cr72 Cr78 Cr111 Cr176 CrSign in free for the trailing twelve months
EBITDA0.67 Cr2 Cr3 Cr3 Cr2 Cr4 Cr6 CrSign in free for the trailing twelve months
OPM %2.3%3.2%4.2%3.7%2.8%3.2%3.4%Sign in free for the trailing twelve months
Other income0.05 Cr0.02 Cr0.04 Cr0.29 Cr2 Cr2 Cr2 CrSign in free for the trailing twelve months
Interest0.14 Cr0.58 Cr0.54 Cr0.48 Cr0.56 Cr0.33 Cr0.73 CrSign in free for the trailing twelve months
Depreciation0.19 Cr0.58 Cr1 Cr1 Cr0.87 Cr1 Cr2 CrSign in free for the trailing twelve months
Profit before tax0.39 Cr0.50 Cr1 Cr2 Cr3 Cr4 Cr6 CrSign in free for the trailing twelve months
Tax %28.8%26.0%28.2%28.7%27.9%22.1%24.7%Sign in free for the trailing twelve months
Net profit0.28 Cr0.37 Cr1 Cr1 Cr2 Cr3 Cr4 CrSign in free for the trailing twelve months
EPS (₹)—₹0.37₹1.05₹1.94₹0.25₹0.20₹0.25Sign in free for the trailing twelve months
Dividend payout %—0.0%0.0%0.0%0.0%0.0%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital0.33 Cr10 Cr10 Cr18 Cr18 Cr34 Cr34 Cr
Reserves0.64 Cr6 Cr6 Cr24 Cr25 Cr54 Cr57 Cr
Borrowings5 Cr7 Cr5 Cr5 Cr2 Cr2 Cr18 Cr
Other liabilities7 Cr6 Cr7 Cr12 Cr3 Cr5 Cr11 Cr
Total liabilities13 Cr28 Cr29 Cr59 Cr48 Cr95 Cr120 Cr
Fixed assets (net)1 Cr5 Cr6 Cr6 Cr10 Cr11 Cr26 Cr
CWIP———0.26 Cr0.92 Cr0.29 Cr0 Cr
Investments6 Cr1 Cr0.70 Cr4 Cr2 Cr3 Cr2 Cr
Loans & advances———4 Cr4 Cr13 Cr14 Cr
Inventories4 Cr5 Cr6 Cr7 Cr15 Cr24 Cr39 Cr
Trade receivables1 Cr14 Cr14 Cr21 Cr13 Cr16 Cr18 Cr
Cash & bank0.10 Cr0.24 Cr0.06 Cr0.31 Cr0.43 Cr7 Cr0.42 Cr
Other assets0.39 Cr2 Cr2 Cr17 Cr2 Cr20 Cr20 Cr
Total assets13 Cr28 Cr29 Cr59 Cr48 Cr95 Cr120 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity-0.67 Cr1 Cr4 Cr-6 Cr-4 Cr-18 Cr-6 Cr
Cash from investing-7 Cr-3 Cr-2 Cr-16 Cr8 Cr-17 Cr-16 Cr
Cash from financing7 Cr2 Cr-2 Cr22 Cr-4 Cr25 Cr15 Cr
Net cash flow0.03 Cr0.12 Cr-0.19 Cr0.25 Cr0.12 Cr-10 Cr-6 Cr
Free cash flow (OCF − Capex)-2 Cr-2 Cr2 Cr-8 Cr-10 Cr-20 Cr-24 Cr

Ratios

MetricMar 2017Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %8.7%4.9%9.2%4.4%7.9%5.2%5.9%
ROE %28.4%2.4%6.4%2.7%5.1%3.8%4.7%
Debtor days179868100595136
Inventory days63453339809097
Days payable4145395681322
Cash conversion cycle39986383131128111
OCF / EBITDA %n.m.70.3%119.8%-201.7%n.m.-480.9%-91.7%
OCF / EBITDA % (3 years)———-9.8%-72.4%-313.9%-225.2%
Debt / equity5.220.430.330.120.050.020.19
Current ratio0.73——2.2810.7412.862.72
Net debt / EBITDA7.46——1.760.78-1.332.77